Literature DB >> 26504176

ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation.

Maria Lindahl1, Jitka Petrlova2, Jonathan Dalla-Riva2, Sebastian Wasserstrom3, Catarina Rippe4, Joan Domingo-Espin2, Dorota Kotowska3, Ewa Krupinska2, Christine Berggreen5, Helena A Jones6, Karl Swärd4, Jens O Lagerstedt2, Olga Göransson5, Karin G Stenkula7.   

Abstract

ApoA-I, the main protein component of HDL, is suggested to be involved in metabolic homeostasis. We examined the effects of Milano, a naturally occurring ApoA-I variant, about which little mechanistic information is available. Remarkably, high-fat-fed mice treated with Milano displayed a rapid weight loss greater than ApoA-I WT treated mice, and a significantly reduced adipose tissue mass, without an inflammatory response. Further, lipolysis in adipose cells isolated from mice treated with either WT or Milano was increased. In primary rat adipose cells, Milano stimulated cholesterol efflux and increased glycerol release, independently of β-adrenergic stimulation and phosphorylation of hormone sensitive lipase (Ser563) and perilipin (Ser522). Stimulation with Milano had a significantly greater effect on glycerol release compared with WT but similar effect on cholesterol efflux. Pharmacological inhibition or siRNA silencing of ABCA1 did not diminish Milano-stimulated lipolysis, although binding to the cell surface was decreased, as analyzed by fluorescence microscopy. Interestingly, methyl-β-cyclodextrin, a well-described cholesterol acceptor, dose-dependently stimulated lipolysis. Together, these results suggest that decreased fat mass and increased lipolysis following Milano treatment in vivo is partly explained by a novel mechanism at the adipose cell level comprising stimulation of lipolysis independently of the canonical cAMP/protein kinase A signaling pathway.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  adenosine 3′,5′-cyclic monophosphate; adipose tissue; apolipoprotein A-I; cholesterol; diabetes; obesity; protein kinase A

Mesh:

Substances:

Year:  2015        PMID: 26504176      PMCID: PMC4655981          DOI: 10.1194/jlr.M054767

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

1.  Adipocytes recognize and degrade oxidized low density lipoprotein through CD36.

Authors:  Akihiko Kuniyasu; Shigeki Hayashi; Hitoshi Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2002-07-12       Impact factor: 3.575

2.  REMOVAL AND METABOLISM OF TRIGLYCERIDES BY PERFUSED LIVER.

Authors:  M RODBELL; R O SCOW; S S CHERNICK
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

3.  Purification and ATPase activity of human ABCA1.

Authors:  Kei Takahashi; Yasuhisa Kimura; Noriyuki Kioka; Michinori Matsuo; Kazumitsu Ueda
Journal:  J Biol Chem       Date:  2006-02-24       Impact factor: 5.157

4.  Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

Authors:  Babak Razani; Terry P Combs; Xiao Bo Wang; Philippe G Frank; David S Park; Robert G Russell; Maomi Li; Baiyu Tang; Linda A Jelicks; Philipp E Scherer; Michael P Lisanti
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

5.  A novel efflux-recapture process underlies the mechanism of high-density lipoprotein cholesteryl ester-selective uptake mediated by the low-density lipoprotein receptor-related protein.

Authors:  Gerard Vassiliou; Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-03       Impact factor: 8.311

6.  International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

Authors:  Beverley Balkau; John E Deanfield; Jean-Pierre Després; Jean-Pierre Bassand; Keith A A Fox; Sidney C Smith; Philip Barter; Chee-Eng Tan; Luc Van Gaal; Hans-Ulrich Wittchen; Christine Massien; Steven M Haffner
Journal:  Circulation       Date:  2007-10-23       Impact factor: 29.690

7.  Exchange of free cholesterol between low density lipoproteins and human adipocytes.

Authors:  A Angel; R Yuen; J A Nettleton
Journal:  Can J Biochem       Date:  1981-08

8.  Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes.

Authors:  Karima Bencharif; Laurence Hoareau; Ravi K Murumalla; Evelyne Tarnus; Frank Tallet; Roger G Clerc; Christophe Gardes; Maya Cesari; Régis Roche
Journal:  Lipids Health Dis       Date:  2010-07-20       Impact factor: 3.876

9.  Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux.

Authors:  Soazig Le Lay; Macarena Rodriguez; Wendy Jessup; Carles Rentero; Qiong Li; Siân Cartland; Thomas Grewal; Katharina Gaus
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

10.  Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice.

Authors:  Karin G Stenkula; Maria Lindahl; Jitka Petrlova; Jonathan Dalla-Riva; Olga Göransson; Samuel W Cushman; Ewa Krupinska; Helena A Jones; Jens O Lagerstedt
Journal:  Diabetologia       Date:  2014-01-18       Impact factor: 10.122

View more
  5 in total

1.  Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.

Authors:  Qing-Hua Yin; Rui Zhang; Li Li; Yi-Ting Wang; Jing-Ping Liu; Jie Zhang; Lin Bai; Jing-Qiu Cheng; Ping Fu; Fang Liu
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

2.  Intact glucose uptake despite deteriorating signaling in adipocytes with high-fat feeding.

Authors:  Björn Hansson; Sebastian Wasserstrom; Björn Morén; Vipul Periwal; Petter Vikman; Samuel W Cushman; Olga Göransson; Petter Storm; Karin G Stenkula
Journal:  J Mol Endocrinol       Date:  2018-01-16       Impact factor: 5.098

Review 3.  The unsolved mystery of apoA-I recycling in adipocyte.

Authors:  Shuai Wang; Dao-quan Peng; Yuhong Yi
Journal:  Lipids Health Dis       Date:  2016-02-24       Impact factor: 3.876

4.  Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner.

Authors:  Björn Hansson; Catarina Rippe; Dorota Kotowska; Sebastian Wasserstrom; Johanna Säll; Olga Göransson; Karl Swärd; Karin G Stenkula
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

5.  Visualization of lipid directed dynamics of perilipin 1 in human primary adipocytes.

Authors:  Jesper S Hansen; Sofia de Maré; Helena A Jones; Olga Göransson; Karin Lindkvist-Petersson
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.